Cargando…
Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their due
Ex vivo feeder-free autologous NK cell expansion is an efficient modality for clinical translation. In this issue of Cell Reports Medicine, Nahi et al. describe the use of this approach as consolidation therapy for multiple myeloma,(1) thereby reviving an alternate avenue for NK cell therapy.
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861944/ https://www.ncbi.nlm.nih.gov/pubmed/35243428 http://dx.doi.org/10.1016/j.xcrm.2022.100537 |